Preclinical Imaging of the Immune System
Curriculum vitae and Publications

Email: Bettina.Weigelin( at )med.uni-tuebingen.de
Phone: +49 7071 29 87414
Fax: +49 7071 29 4451

Research interest

Immunotherapy is an emerging first-line treatment to target advanced cancer, with the potential to reach long-lasting regression and cure. Most solid tumors respond to immunotherapy to a variable degree, however, the majority of patients experience resistance to therapy followed by relapse. The group ‘Preclinical Imaging of the Immune System’ combines advanced microscopic techniques with state-of-the-art macroscopic imaging to gain mechanistic insight in kinetics and function of immunotherapies at the cellular and whole-body scale. The visualization of immunotherapy response in live tumor tissue and over time allows the identification of tissue-specific resistance niches and rationales for improved cancer immunotherapies.